Drug Eluting Stents (DES) Market Trends, Growth, Revenue Analysis and Major Key Pillars-Abbott, B. Braun Melsungen AG, Biosensors International Group, BIOTRONIK SE & Co.
The Global Drug Eluting Stents (DES) Industry is estimated to generate $ 9.20 billion by 2026, growing at a CAGR of 5.35% from 2020 to 2027, according to a report by Data Bridge Market Research.
View full press release